| Dr Carlos Alberto Rueda Rios, MD | |
|
1249 15th St Ste 4000, Huntington, WV 25701-3663 | |
| (304) 691-8500 | |
| (304) 691-8510 |
| Full Name | Dr Carlos Alberto Rueda Rios |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 17 Years |
| Location | 1249 15th St Ste 4000, Huntington, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154617678 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
| St Mary's Medical Center | Huntington, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians And Surgeons, Inc | 2961315734 | 324 |
News Archive
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Individuals and organizations providing or increasing access to quality radiological services for patients in low- to middle-income countries and underserved areas of the United States are encouraged to apply for the American College of Radiology Foundation's new Global Humanitarian Awards.
"California Rep. Howard Berman, the top Democrat on the Foreign Affairs Committee, unveiled a 923-page bill on Wednesday that would replace the Foreign Assistance Act of 1961 with a framework for providing developmental and economic U.S. aid," the Associated Press/Huffington Post reports, noting, "Berman's Global Partnerships Act of 2012 would change the aid system to focus on mutually agreed goals instead of the emphasis on donor-recipient ties, increase accountability and oversight, and eliminate duplication."
Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient's own bone marrow. The research, published in STEM CELLS, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies.
Isis Pharmaceuticals, Inc. today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).
› Verified 1 days ago
| Entity Name | University Physicians & Surgeons, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730183286 PECOS PAC ID: 2961315734 Enrollment ID: O20031107000331 |
News Archive
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Individuals and organizations providing or increasing access to quality radiological services for patients in low- to middle-income countries and underserved areas of the United States are encouraged to apply for the American College of Radiology Foundation's new Global Humanitarian Awards.
"California Rep. Howard Berman, the top Democrat on the Foreign Affairs Committee, unveiled a 923-page bill on Wednesday that would replace the Foreign Assistance Act of 1961 with a framework for providing developmental and economic U.S. aid," the Associated Press/Huffington Post reports, noting, "Berman's Global Partnerships Act of 2012 would change the aid system to focus on mutually agreed goals instead of the emphasis on donor-recipient ties, increase accountability and oversight, and eliminate duplication."
Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient's own bone marrow. The research, published in STEM CELLS, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies.
Isis Pharmaceuticals, Inc. today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carlos Alberto Rueda Rios, MD 1448 10th Ave Ste 304, Huntington, WV 25701-3579 Ph: () - | Dr Carlos Alberto Rueda Rios, MD 1249 15th St Ste 4000, Huntington, WV 25701-3663 Ph: (304) 691-8500 |
News Archive
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Individuals and organizations providing or increasing access to quality radiological services for patients in low- to middle-income countries and underserved areas of the United States are encouraged to apply for the American College of Radiology Foundation's new Global Humanitarian Awards.
"California Rep. Howard Berman, the top Democrat on the Foreign Affairs Committee, unveiled a 923-page bill on Wednesday that would replace the Foreign Assistance Act of 1961 with a framework for providing developmental and economic U.S. aid," the Associated Press/Huffington Post reports, noting, "Berman's Global Partnerships Act of 2012 would change the aid system to focus on mutually agreed goals instead of the emphasis on donor-recipient ties, increase accountability and oversight, and eliminate duplication."
Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient's own bone marrow. The research, published in STEM CELLS, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies.
Isis Pharmaceuticals, Inc. today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).
› Verified 1 days ago
Leonard White, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1249 15th St, Suite 2000, Huntington, WV 25701 Phone: 304-691-1000 Fax: 304-691-1153 | |
George J Linsenmeyer Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1249 15th St Ste 4000, Huntington, WV 25701 Phone: 304-691-8500 | |
Maria Gracia Luzuriaga Bassante, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1249 15th St Ste 3000, Huntington, WV 25701 Phone: 304-691-1000 | |
Dr. Everett B Wray Iii, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1249 15th Street, Suite 4000, Huntington, WV 25701 Phone: 304-691-8500 Fax: 304-691-8510 | |
Mustafa Awili, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 First Avenue, Room 1025, Huntington, WV 25702 Phone: 304-399-7484 Fax: 304-399-7579 | |
Helgi K Sigmundsson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5170 Us Rt 60 East, Huntington, WV 25705 Phone: 304-528-4600 | |
Sara Catherine Allman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1540 Spring Valley Dr, Huntington, WV 25704 Phone: 304-429-6741 Fax: 304-429-0362 |